Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | TMPRSS15 | P98073 | 2/20 | 0.54 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.54 |
| ▸ | ACR | P10323 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | NSD2 | O96028 | 1/20 | 0.51 |
| ▸ | RXRA | P19793 | 1/20 | 0.51 |
| ▸ | RXRB | P28702 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL27731497 | 0.93 | LMNA (0.54) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| SCHEMBL4905240 | 0.93 | KMT2A (0.62) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| Benzoquinone SCHEMBL28914486 | 0.92 | RAB9A (0.50) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| SCHEMBL12154217 | 0.90 | ALDH1A1 (0.57) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| SCHEMBL12154283 | 0.90 | ALDH1A1 (0.57) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| SCHEMBL26832415 | 0.90 | ALDH1A1 (0.57) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| SCHEMBL12199916 | 0.90 | ALDH1A1 (0.57) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| SCHEMBL3771392 | 0.88 | KMT2A (0.56) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| SCHEMBL11672038 | 0.87 | ALDH1A1 (0.71) | RAB9AALDH1A1PARP10MAPTSMN1; SMN2 | |
| SCHEMBL19220417 | 0.87 | PRSS1 (0.52) | RAB9AALDH1A1MAPTSMN1; SMN2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113999386-B | Polyaryletherketone resin containing carboxyl side group and synthesis method thereof | 浙江鹏孚隆新材料有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-113999386-A | Polyaryletherketone resin containing carboxyl side group and synthesis method thereof | 浙江鹏孚隆新材料有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-109553555-B | Synthesis method of 4-methyl-N-phenyl-N- (2-phenylpropyl-1-alkenyl) benzene sulfonamide compound | 山东理工大学 | 2021-01-08 | — | — | CN | disclosed |
| CN-105492469-B | Catalyst components for the polymerization of olefins | 巴塞尔聚烯烃意大利有限公司 | 2018-07-17 | — | — | CN | disclosed |
| US-8182975-B2 | Positive resist composition and pattern forming method using the same | FUJIFILM CORPORATION (JP) | 2012-05-22 | — | — | US | disclosed |
| EP-1897928-B1 | Chlorofluorobenzene liquid crystal compound, liquid crystal composition and liquid crystal display device | CHISSO CORP (JP) | 2010-10-27 | — | — | EP | disclosed |
| US-7786122-B2 | α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-08-31 | — | — | US | disclosed |
| US-20080248419-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2008-10-09 | — | — | US | disclosed |
| US-20080085894-A1 | ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-04-10 | — | — | US | disclosed |
| US-7189782-B2 | Thermoplastic film, thermoplastic resin composition, and phyllosilicate | TEIJIN LIMITED (JP) | 2007-03-13 | — | — | US | disclosed |
| EP-1412411-B1 | PROCESS FOR PREPARING POLYCARBONATE AND APPARATUS FOR PREPARING POLYCARBONATE | GEN ELECTRIC (US) | 2006-08-09 | — | — | EP | disclosed |
| EP-1412411-A2 | PROCESS FOR PREPARING POLYCARBONATE AND APPARATUS FOR PREPARING POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2004-04-28 | — | — | EP | disclosed |
| US-6620902-B2 | Melting aromatic dihydroxy compound, a carbonic acid diester; mixing with endcapping agent under hermetic sealing | GENERAL ELECTRIC COMPANY | 2003-09-16 | — | — | US | disclosed |
| WO-2003008481-A2 | PROCESS FOR PREPARING POLYCARBONATE AND APPARATUS FOR PREPARING POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2003-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080085894-A1 | ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS | APP, APBA1, BACE1 | RAB9A 1585/4885ALDH1A1 1197/4885PARP10 3036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.